Category: Licensing/Collaboration Deal Region: North America · Canada Company: The University Of Arizona

Sunshine Biopharma Inks Agreement With University Of Arizona To Advance Anti-Coronavirus Drug Development Programme

Sunshine Biopharma Inks Agreement With University Of Arizona To Advance Anti-Coronavirus Drug Development Programme
Sunshine Biopharma, Inc., A Pharmaceutical Company Focused On The Research, Development And Commercialization Of Oncology And Antiviral Drugs, Announced That It Has Entered Into An Agreement With The University Of Arizona For The Purposes Of Advancing The Development Of Novel Plpro Inhibitors Discovered By University Of Arizona And University Of Illinois Chicago Researchers.The Development Of The Company

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!